Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
4.069
+0.289 (7.63%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nanobiotix Employees
Nanobiotix had 102 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
102
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$443,335
Profits / Employee
-$351,620
Market Cap
178.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
Biodesix | 217 |
Caribou Biosciences | 158 |
Tenaya Therapeutics | 140 |
BrainsWay | 134 |
Senseonics Holdings | 132 |
Heron Therapeutics | 126 |
MediWound | 100 |
NBTX News
- 9 days ago - NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms - GlobeNewsWire
- 21 days ago - NANOBIOTIX to Participate in Multiple Investor Conferences in November - GlobeNewsWire
- 2 months ago - NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth - GlobeNewsWire
- 2 months ago - Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024 - GlobeNewsWire
- 6 months ago - Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy - GlobeNewsWire
- 6 months ago - NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call - GlobeNewsWire